2025-04-05 - Analysis Report
## Procter & Gamble Co (PG) Stock Report

**0) Overview:** Procter & Gamble Co (PG) is a multinational consumer goods company that manufactures and markets a wide range of products.

**1) Performance Comparison:**

PG's cumulative return of 61.71% lags behind the S&P 500's (VOO) return of 71.02% by 9.3 percentage points.  The relative divergence of -9.3% places PG at the 53.8th percentile of its historical range of performance relative to the S&P 500 (-44.3% to +20.7%).  This indicates that while PG underperformed the S&P 500 in this period, it's not an extreme outlier in the context of its historical performance against the benchmark.

**Alpha and Beta Analysis:**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 22.0% | 7.9% | -8.0% | 0.0 | 177.8 |
| 2016-2018  | 4.0% | 56.7% | -13.0% | 0.3 | 184.2 |
| 2017-2019  | 32.0% | 56.7% | 3.0% | 0.4 | 257.3 |
| 2018-2020  | 48.0% | 56.7% | 18.0% | 0.5 | 293.7 |
| 2019-2021  | 64.0% | 9.6% | -10.0% | 0.5 | 354.0 |
| 2020-2022  | 25.0% | 74.7% | 5.0% | 0.5 | 336.1 |
| 2021-2023  | 20.0% | 74.7% | -8.0% | 0.4 | 333.2 |
| 2022-2024  | -4.0% | 74.7% | -19.0% | 0.3 | 390.7 |
| 2023-2025  | -2.0% | 80.2% | -5.0% | 0.2 | 384.0 |

The data shows fluctuating alpha values, suggesting periods of both outperformance and underperformance relative to the market.  The beta consistently hovers around 0.3-0.5, indicating moderate sensitivity to overall market movements.  Market capitalization has generally increased over the period.

**2) Recent Price Movement:**

* **Closing Price:** $163.75
* **5-day Moving Average:** $169.32
* **20-day Moving Average:** $168.65
* **60-day Moving Average:** $167.71

The price is below all three moving averages, suggesting a bearish short-term trend.  The recent price change of -$5.01 (-2.9%) indicates a significant daily drop.


**3) Technical Indicators & Expected Return:**

* **Market Risk Indicator (MRI):** 0.4693 (High Risk)
* **RSI:** 40.08 (approaching oversold territory)
* **PPO:** -0.0358 (slightly bearish)
* **20-day Relative Divergence Change:** +16.1% (short-term upward momentum)
* **Expected Return:** -7.9%  This suggests a negative expected return in the short term. The long-term (2+ years) expected return relative to the S&P 500 is not explicitly provided and would require a more detailed model.

The recent price drop is reflected in the RSI nearing oversold levels and the negative PPO. However, the positive relative divergence change hints at potential short-term upward momentum. The MRI indicates high risk.

**4) Recent Earnings Analysis:**

| Date       | EPS  | Revenue       |
|------------|------|---------------|
| 2025-01-22 | 1.94 | $21.88B       |
| 2024-10-18 | 1.65 | $21.74B       |
| 2024-04-19 | 1.56 | $20.20B       |
| 2024-01-23 | 1.44 | $21.44B       |
| 2025-01-22 | 1.44 | $21.44B       | *(Duplicate Entry - likely an error)*


Revenue shows some fluctuation, with a slight decrease in Q2 2024. EPS shows an upward trend except for one data point in Q1 2024, indicating a possible error.  Further investigation of the data source is needed to verify the duplicate entry and apparent inconsistencies.


**5) Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue  | Profit Margin |
|---------|----------|---------------|
| 2024-12-31 | $21.88B | 52.39%       |
| 2024-09-30 | $21.74B | 52.06%       |
| 2024-06-30 | $20.53B | 49.60%       |
| 2024-03-31 | $20.20B | 51.20%       |
| 2023-12-31 | $21.44B | 52.69%       |

Profit margins are consistently high, although there's a slight dip in Q2 2024.  Revenue shows some seasonal variation but remains relatively stable.

**Capital and Profitability:**

| Quarter | Equity   | ROE    |
|---------|----------|--------|
| 2024-12-31 | $51.17B | 9.05%  |
| 2024-09-30 | $51.84B | 7.64%  |
| 2024-06-30 | $50.29B | 6.24%  |
| 2024-03-31 | $50.06B | 7.50%  |
| 2023-12-31 | $48.53B | 7.15%  |

Equity fluctuates, and ROE shows some variability, suggesting potential impacts from various factors affecting profitability and capital structure.


**6)  Overall Analysis:**

PG shows mixed signals.  While it boasts strong revenue and high profit margins, its recent performance lags behind the S&P 500. Short-term indicators suggest bearish sentiment, though the recent relative divergence suggests some short-term upward momentum. The high market risk indicator suggests caution.  Further investigation is needed to clarify the inconsistencies in the earnings data. A long-term investment strategy might be considered, but a thorough analysis including a more robust long-term expected return model, is recommended before making any investment decisions. The high profit margins and relatively stable revenue suggest the company's underlying fundamentals are generally strong. However, careful consideration of its relative performance and current market risk is vital.
